S&P 500 Futures
(-0.15%) 5 245.25 points

Dow Jones Futures
(0.01%) 38 233 points

Nasdaq Futures
(-0.30%) 18 551 points

Oil
(0.10%) $77.99

Gas
(-0.93%) $2.55

Gold
(-0.10%) $2 364.10

Silver
(-0.46%) $31.39

Platinum
(-0.48%) $1 033.00

USD/EUR
(-0.04%) $0.923

USD/NOK
(-0.07%) $10.53

USD/GBP
(0.13%) $0.786

USD/RUB
(0.04%) $90.30

Realtime updates for Torii Pharmaceutical Co., [4551.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Last Updated31 May 2024 @ 02:15

25% discount on Stockinvest.us - Use code: Podcast

2.02% ¥ 3 785.00

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 02:15):

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients...

Stats
Today's Volume	35 300.00
Average Volume	25 293.00
Market Cap	106.38B
EPS	¥0 ( 2024-04-25 )
Next earnings date	( ¥0 ) 2024-07-29
Last Dividend	¥50.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	20.13
ATR14	¥5.02 (0.13%)

Volume Correlation

Long: -0.04 (neutral)

Short: 0.06 (neutral)

Signal:(55.909) Neutral

Torii Pharmaceutical Co., Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Torii Pharmaceutical Co., Correlation - Currency/Commodity

0.39
( neutral )

0.03
( neutral )

-0.83
( strong negative )

-0.12
( neutral )

-0.87
( strong negative )

0.80
( moderate )

Torii Pharmaceutical Co., Financials

Annual	2023
Revenue:	¥54.64B
Gross Profit:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2023
Revenue:	¥54.64B
Gross Profit:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2022
Revenue:	¥48.89B
Gross Profit:	¥23.38B (47.81 %)
EPS:	¥140.38

FY	2021
Revenue:	¥46.99B
Gross Profit:	¥24.34B (51.80 %)
EPS:	¥32.16

Financial Reports:

No articles found.

Torii Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥76.00 (N/A)	¥0 (N/A)	¥50.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Torii Pharmaceutical Co., Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.73 - average (90.96%) | Divividend Growth Potential Score: 2.11 - Decrease likely (57.90%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.00	2001-03-27
Last Dividend	¥50.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	¥907.00	--
Avg. Dividend % Per Year	0.00%	--
Score	2.79	--
Div. Sustainability Score	6.73
Div.Growth Potential Score	2.11
Div. Directional Score	4.42	--

Next Divdend (Est)
(2024-09-25)

¥0 Estimate 3.76 %

Dividend Stability

0.30 Poor

Dividend Score

2.79

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
8345.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
7729.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
6902.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
6264.T	Ex Dividend Junior	2023-08-30	Semi-Annually	0	0.00%
4975.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
4187.T	Ex Dividend Knight	2023-11-29	Semi-Annually	0	0.00%
3388.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
2462.T	Ex Dividend Knight	2023-11-29	Semi-Annually	0	0.00%
9982.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0	0.00%
8966.T	Ex Dividend Junior	2023-11-29	Semi-Annually	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0939	1.500	8.12	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0398	1.200	8.67	10.00	[0 - 0.3]
returnOnEquityTTM	0.0444	1.500	-0.618	-0.927	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	6.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.20	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.280	1.500	9.56	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	24.91	2.00	1.698	3.40	[0 - 30]
freeCashFlowPerShareTTM	24.91	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.448	1.000	5.86	5.86	[0.2 - 0.8]
operatingProfitMarginTTM	0.122	1.000	9.56	9.56	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.423	0.800	-0.511	-0.409	[0.5 - 2]
Total Score				6.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	19.94	1.000	8.09	0	[1 - 100]
returnOnEquityTTM	0.0444	2.50	-0.397	-0.927	[0.1 - 1.5]
freeCashFlowPerShareTTM	24.91	2.00	1.698	10.00	[0 - 30]
dividendYielPercentageTTM	3.20	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	24.91	2.00	1.698	3.40	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.436	1.500	-0.430	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0124	1.000	-2.19	0	[0.1 - 0.5]
Total Score				2.11

Torii Pharmaceutical Co., Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Torii Pharmaceutical Co.,

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.